Anti–PD-1/PD-L1 Blockade Immunotherapy Employed in Treating Hepatitis B Virus Infection–Related Advanced Hepatocellular Carcinoma: A Literature Review

Hepatitis B virus (HBV) infection is regarded as the main etiological risk factor in the process of hepatocellular carcinoma (HCC), as it promotes an immunosuppressive microenvironment that is partially mediated by the programmed cell death protein 1 (PD-1)/programmed death-ligand 1 (PD-L1) signalin...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Bin Li, Cong Yan, Jiamin Zhu, Xiaobing Chen, Qihan Fu, Hangyu Zhang, Zhou Tong, Lulu Liu, Yi Zheng, Peng Zhao, Weiqin Jiang, Weijia Fang
Médium: Artigo
Jazyk:Inglês
Vydáno: Frontiers Media S.A. 2020-05-01
Edice:Frontiers in Immunology
Témata:
immunotherapy
hepatocellular carcinoma
hepatitis B virus
programmed cell death protein 1
programmed death-ligand 1
tumor microenvironment
On-line přístup:https://www.frontiersin.org/article/10.3389/fimmu.2020.01037/full
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky